Max Healthcare Q2 Revenue Hits Rs 2,569 Crore; Profit Declines YoY

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Max Healthcare Q2 Revenue Hits Rs 2,569 Crore; Profit Declines YoY

Max Healthcare reported a consolidated revenue of Rs 2,569.21 crore for Q2 FY27, up from Rs 2,135.47 crore. Despite top-line growth, net profit slipped to Rs 414.45 crore from Rs 491.30 crore in the same quarter last year. The company announced major capacity expansions in Noida and Vaishali, alongside a cost revision for its upcoming 525-bed Gurugram facility.

Max Healthcare Q2 Results and Expansion Plans

Max Healthcare reported revenue of Rs 2,569.21 crore and a net profit of Rs 414.45 crore for the quarter ended September 30, 2026.

Reader Takeaway: Strong revenue growth driven by network reach, though higher costs impact short-term bottom-line margins during expansion phase.

What just happened

Max Healthcare posted a revenue increase for Q2 FY27 compared to Q2 FY26. However, net profit for the quarter declined to Rs 414.45 crore, down from Rs 491.30 crore in the previous year. For the half-year period, revenue reached Rs 4,935.38 crore, while net profit stood at Rs 737.41 crore.

Why this matters

The company is betting heavily on future growth through infrastructure scaling. It approved Rs 190 crore in new capex for expansions in Noida and Vaishali, which will add 145 beds to its network. These projects are critical to maintaining market share in high-demand regions but place immediate pressure on cash flows and margins.

The backstory

The hospital chain has been aggressively increasing its footprint. It recently completed a majority acquisition in Kalinga Hospital Ltd, raising its stake to 66.34% by September 2026. Simultaneously, it is streamlining operations by winding up its Nigerian subsidiary.

What changes now

Investors must track the Gurugram project, where costs have been revised to Rs 1,143 crore with a new completion target of April 2027. Changes in building specifications and interior fit-outs led to this revision, signaling a potential trend of rising construction costs.

Risks to watch

Profitability margins are currently under pressure due to both capital expenditure and operational costs. Execution risk remains the primary concern, as timelines for the Noida, Vaishali, and Gurugram projects will dictate the timing of returns on invested capital.

Management update

Dr. Dharmender Kumar has joined the leadership team as Director & Chief - Public Affairs effective November 1, 2026, marking a shift in the company's senior management structure.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.